University of Maryland professor receives award for hyperthermic oncology research

Zeljko Vujaskovic , MD, PhD, professor of radiation oncology at University of Maryland School of Medicine, received the J. Eugene Robinson Award.

The award recognizes significant contributions to hyperthermic oncology, or the use of heat to treat cancer.

Zeljko Vujaskovic

Zeljko Vujaskovic

Vujaskovic — who received the award at the Society for Thermal Medicine Annual Meeting in New Orleans — is director of the division of translational radiation sciences and director of the Maryland Proton Alliance at University of Maryland.

“This is well-deserved recognition for Dr. Vujaskovic, who has been a true pioneer in exploring new and innovative therapies for eradicating deadly cancers,” William F. Regine, MD, FACR, FACRO, chairman and professor of radiation oncology and executive director of the Maryland Proton Treatment Center, said in a press release. “We are very fortunate to have him on our faculty, as he continues to develop future clinical care protocols [and] new novel therapies, and leads our efforts to improve radiation treatments and the quality of life for [patients with cancer].”

Vujaskovic began his academic career as assistant professor in the departments of radiotherapy and clinical radiobiology at University of Groningen School of Medicine in the Netherlands. He also served in the department of radiation oncology at Duke University before joining University of Maryland.

Zeljko Vujaskovic , MD, PhD, professor of radiation oncology at University of Maryland School of Medicine, received the J. Eugene Robinson Award.

The award recognizes significant contributions to hyperthermic oncology, or the use of heat to treat cancer.

Zeljko Vujaskovic

Zeljko Vujaskovic

Vujaskovic — who received the award at the Society for Thermal Medicine Annual Meeting in New Orleans — is director of the division of translational radiation sciences and director of the Maryland Proton Alliance at University of Maryland.

“This is well-deserved recognition for Dr. Vujaskovic, who has been a true pioneer in exploring new and innovative therapies for eradicating deadly cancers,” William F. Regine, MD, FACR, FACRO, chairman and professor of radiation oncology and executive director of the Maryland Proton Treatment Center, said in a press release. “We are very fortunate to have him on our faculty, as he continues to develop future clinical care protocols [and] new novel therapies, and leads our efforts to improve radiation treatments and the quality of life for [patients with cancer].”

Vujaskovic began his academic career as assistant professor in the departments of radiotherapy and clinical radiobiology at University of Groningen School of Medicine in the Netherlands. He also served in the department of radiation oncology at Duke University before joining University of Maryland.